Safety and immunogenicity of high-dose trivalent inactivated influenza vaccine in adults 50–64 years of age

出版年份 2015 全文链接

标题

作者

关键词

Influenza vaccines, Inactivated, Clinical trial, Phase II, Middle aged, Safety

出版物

Volume 33, Issue 51, Pages 7188-7193

出版商

Elsevier BV

发表日期

2015-11-08

DOI

10.1016/j.vaccine.2015.10.131

联系作者

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started